Search details
1.
Prioritization of cancer therapeutic targets using CRISPR-Cas9 screens.
Nature
; 568(7753): 511-516, 2019 04.
Article
in English
| MEDLINE | ID: mdl-30971826
2.
MK-4827, a PARP-1/-2 inhibitor, strongly enhances response of human lung and breast cancer xenografts to radiation.
Invest New Drugs
; 30(6): 2113-20, 2012 Dec.
Article
in English
| MEDLINE | ID: mdl-22127459
3.
The promise and peril of chemical probes.
Nat Chem Biol
; 11(8): 536-41, 2015 Aug.
Article
in English
| MEDLINE | ID: mdl-26196764
4.
Corrigendum: The promise and peril of chemical probes.
Nat Chem Biol
; 11(11): 887, 2015 Nov.
Article
in English
| MEDLINE | ID: mdl-26485080
5.
Potent N-(1,3-thiazol-2-yl)pyridin-2-amine vascular endothelial growth factor receptor tyrosine kinase inhibitors with excellent pharmacokinetics and low affinity for the hERG ion channel.
J Med Chem
; 47(25): 6363-72, 2004 Dec 02.
Article
in English
| MEDLINE | ID: mdl-15566305
6.
Predictive genes in adjacent normal tissue are preferentially altered by sCNV during tumorigenesis in liver cancer and may rate limiting.
PLoS One
; 6(7): e20090, 2011.
Article
in English
| MEDLINE | ID: mdl-21750698
Results
1 -
6
de 6
1
Next >
>>